459867-30-2

Basic information

• Product Name: (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene
• Synonyms: (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene
• CAS NO: 459867-30-2
• Molecular Weight: 366.457
• Mol File: 459867-30-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene(459867-30-2)
• EPA Substance Registry System: (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4,5-(isopropylidenedioxy)-2-cyclopentene(459867-30-2)

Safety Data

• Hazardous Substances Data: 459867-30-2(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 89291-76-9 (1S,4R,5S)-(-)-3-<(benzyloxy)methyl>-4,5-O-isopropylidene-2-cyclopenten-1-ol 

Downstream Products

• 459867-38-0 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-(methoxy)methoxy-cyclopent-3-en-1-yl]-6-chloropurine 
• 459867-40-4 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-hydroxy-cyclopent-3-en-1-yl]-6-aminopurine 
• 459867-39-1 (+)-9-[(1R,2R,5S)-5-benzyloxy-3-(benzyloxy)methyl-2-hydroxy-cyclopent-3-en-1-yl]-6-chloropurine 
• 459867-37-9 (1S,4R,5S)-1,5-dibenzyloxy-3-[(benzyloxy)methyl]-4-[(methoxy)methoxy]-cyclopent-2-ene 
• 459867-33-5 (1S,4R,5S)-1,5-di(benzyloxy)-3-[(benzyloxy)methyl]cyclopent-2-en-4-ol 
• 459867-32-4 (1S,4R,5S)-1,4-di(benzyloxy)-3-[(benzyloxy)methyl]cyclopent-2-en-5-ol 
• 459867-36-8 (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-4-[(methoxy)methoxy]-cyclopent-2-en-5-ol 
• 459867-31-3 (1S,4R,5S)-1-benzyloxy-3-[(benzyloxy)methyl]-2-cyclopentene-4,5-diol 

Relevant articles and documents

Enantioselective synthesis of (+)-neplanocin F

(+)-Neplanocin F ((+)-5), a minor component of the neplanocin family of antibiotics was enantioselectively synthesized starting from D-ribono-1,4-lactone via a convergent approach in 14 steps. This synthetic approach employed a regioselective protection of a secondary allylic hydroxyl group over a homoallylic one as key step.